Introduction: Critically ill patients with inflammatory dysregulation and organ disfunction may benefit from blood purification, although the use of this technique has not been described in large case series. We evaluated clinical outcomes and survival in high-risk intensive care unit (ICU) patients who underwent extracorporeal blood purification. Methods: 359 consecutive ICU patients treated with CytoSorb were included. Results: Main admission diagnoses were 120 (34%) refractory cardiac arrest under mechanical chest compression; 101 (28%) profound cardiogenic shock; 81 (23%) post-cardiotomy cardiogenic shock; and 37 (10%) respiratory failure. Fifteen patients (4%) were positive for SARS-CoV-2 infection. We observed 49% 30-day mortality, 57% ICU mortality, and 62% hospital mortality, all lower than the 71% mortality predicted by SAPS II and 68% predicted by SOFA score. Parameters of shock and organ failure, above all vasoactive inotropic score, reduced during CytoSorb treatment. Multivariable analysis identified SAPS II, lactate dehydrogenase, ICU stay duration, vasoactive inotropic score, lactates, intra-aortic counterpulsation on top of VA-ECMO, and total bilirubin as predictors of mortality. No CytoSorb-related complications occurred. Conclusion: CytoSorb treatment was effective in reducing laboratory parameters of shock and vasoactive inotropic score with possible survival implications in a large population of critically ill patients.

1.
Chousterman
BG
,
Swirski
FK
,
Weber
GF
.
Cytokine storm and sepsis disease pathogenesis
.
Semin Immunopathol
.
2017 Jul
39
5
517
28
.
2.
Rugg
C
,
Klose
R
,
Hornung
R
,
Innerhofer
N
,
Bachler
M
,
Schmid
S
.
Hemoadsorption with CytoSorb in septic shock reduces catecholamine requirements and in-hospital mortality: a single-center retrospective “genetic” matched analysis
.
Biomedicines
.
2020 Nov
8
12
539
.
3.
Deans
KJ
,
Haley
M
,
Natanson
C
,
Eichacker
PQ
,
Minneci
PC
.
Novel therapies for sepsis: a review
.
J Trauma
.
2005 Apr
58
4
867
74
.
4.
Ronco
C
,
Tetta
C
,
Mariano
F
,
Wratten
ML
,
Bonello
M
,
Bordoni
V
.
Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis
.
Artif Organs
.
2003 Sep
27
9
792
801
.
5.
Honoré
PM
,
Matson
JR
.
Extracorporeal removal for sepsis: acting at the tissue level–the beginning of a new era for this treatment modality in septic shock
.
Crit Care Med
.
2004 Mar
32
3
896
7
.
6.
Ankawi
G
,
Neri
M
,
Zhang
J
,
Breglia
A
,
Ricci
Z
,
Ronco
C
.
Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls
.
Crit Care
.
2018 Sep
22
1
262
.
7.
Ankawi
G
,
Xie
Y
,
Yang
B
,
Xie
Y
,
Xie
P
,
Ronco
C
.
What have we learned about the use of Cytosorb adsorption columns
.
Blood Purif
.
2019
;
48
(
3
):
196
202
.
8.
Poli
EC
,
Rimmelé
T
,
Schneider
AG
.
Hemoadsorption with CytoSorb®
.
Intensive Care Med
.
2019 Feb
45
2
236
9
.
9.
Rimmelé
T
,
Kellum
JA
.
Clinical review: blood purification for sepsis
.
Crit Care
.
2011
;
15
(
1
):
205
.
10.
Träger
K
,
Fritzler
D
,
Fischer
G
,
Schröder
J
,
Skrabal
C
,
Liebold
A
.
Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series
.
Int J Artif Organs
.
2016 May
39
3
141
6
.
11.
Bernardi
MH
,
Rinoesl
H
,
Dragosits
K
,
Ristl
R
,
Hoffelner
F
,
Opfermann
P
.
Effect of hemoadsorption during cardiopulmonary bypass surgery: a blinded, randomized, controlled pilot study using a novel adsorbent
.
Crit Care
.
2016 Apr
20
96
.
12.
Poli
EC
,
Alberio
L
,
Bauer-Doerries
A
,
Marcucci
C
,
Roumy
A
,
Kirsch
M
.
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
.
Crit Care
.
2019 Apr
23
1
108
.
13.
Biancari
F
,
Perrotti
A
,
Dalén
M
,
Guerrieri
M
,
Fiore
A
,
Reichart
D
.
Meta-analysis of the outcome after postcardiotomy venoarterial extracorporeal membrane oxygenation in adult patients
.
J Cardiothorac Vasc Anesth
.
2018 Jun
32
3
1175
82
.
14.
Pieri
M
,
Belletti
A
,
Monaco
F
,
Pisano
A
,
Musu
M
,
Dalessandro
V
.
Outcome of cardiac surgery in patients with low preoperative ejection fraction
.
BMC Anesthesiol
.
2016 Oct
16
1
97
.
15.
Fukuhara
S
,
Takeda
K
,
Garan
AR
,
Kurlansky
P
,
Hastie
J
,
Naka
Y
.
Contemporary mechanical circulatory support therapy for postcardiotomy shock
.
Gen Thorac Cardiovasc Surg
.
2016 Apr
64
4
183
91
.
16.
Saha
A
,
Kurlansky
P
,
Ning
Y
,
Sanchez
J
,
Fried
J
,
Witer
LJ
.
Early venoarterial extracorporeal membrane oxygenation improves outcomes in post-cardiotomy shock
.
J Artif Organs
.
2021 Mar
24
1
7
14
.
17.
Supady
A
,
Zahn
T
,
Rieder
M
,
Benk
C
,
Lother
A
,
Bode
C
.
Effect of cytokine adsorption on survival and circulatory stabilization in patients receiving extracorporeal cardiopulmonary resuscitation
.
ASAIO J
.
2022 Jan
68
1
64
72
.
18.
Nemeth
E
,
Kovacs
E
,
Racz
K
,
Soltesz
A
,
Szigeti
S
,
Kiss
N
.
Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation-an observational study
.
Clin Transplant
.
2018 Apr
32
4
e13211
.
19.
Kellum
JA
,
Venkataraman
R
,
Powner
D
,
Elder
M
,
Hergenroeder
G
,
Carter
M
.
Feasibility study of cytokine removal by hemoadsorption in brain-dead humans
.
Crit Care Med
.
2008 Jan
36
1
268
72
.
20.
Scandroglio
AM
,
Pieri
M
,
Nardelli
P
,
Fominskiy
E
,
Calabrò
MG
,
Melisurgo
G
.
Impact of CytoSorb on kinetics of vancomycin and bivalirudin in critically ill patients
.
Artif Organs
.
2021 Sep
45
9
1097
103
.
21.
Mehta
P
,
McAuley
DF
,
Brown
M
,
Sanchez
E
,
Tattersall
RS
,
Manson
JJ
.
COVID-19: consider cytokine storm syndromes and immunosuppression
.
Lancet
.
2020 Mar
395
10229
1033
4
.
22.
Masmouei
B
,
Harorani
M
,
Bazrafshan
MR
,
Karimi
Z
.
COVID-19: hyperinflammatory syndrome and hemoadsorption with CytoSorb
.
Blood Purif
.
2021
;
50
(
6
):
976
8
.
23.
Ritchie
AI
,
Singanayagam
A
.
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword
.
Lancet
.
2020 Apr
395
10230
1111
.
24.
Rizvi
S
,
Danic
M
,
Silver
M
,
LaBond
V
.
Cytosorb filter: an adjunct for survival in the COVID-19 patient in cytokine storm? A case report
.
Heart Lung
.
2021 Jan–Feb
50
1
44
50
.
25.
Ronco
C
,
Reis
T
.
Kidney involvement in COVID-19 and rationale for extracorporeal therapies
.
Nat Rev Nephrol
.
2020 Jun
16
6
308
10
.
26.
Pieri
M
,
Fominskiy
E
,
Nardelli
P
,
Bonizzoni
MA
,
Scandroglio
AM
.
CytoSorb purification in critically ill SARS-CoV-2 patients
.
Int J Artif Organs
.
2022 Feb
45
2
216
20
.
27.
Calabrò
MG
,
Febres
D
,
Recca
G
,
Lembo
R
,
Fominskiy
E
,
Scandroglio
AM
.
Blood purification with CytoSorb in critically ill patients: single-center preliminary experience
.
Artif Organs
.
2019 Feb
43
2
189
94
.
28.
Belletti
A
,
Lerose
CC
,
Zangrillo
A
,
Landoni
G
.
Vasoactive-inotropic score: evolution, clinical utility, and pitfalls
.
J Cardiothorac Vasc Anesth
.
2021 Oct
35
10
3067
77
.
29.
Mehran
R
,
Rao
SV
,
Bhatt
DL
,
Gibson
CM
,
Caixeta
A
,
Eikelboom
J
.
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
.
Circulation
.
2011 Jun
123
23
2736
47
.
30.
Nardelli
P
,
Pieri
M
,
Fominskiy
E
,
Scandroglio
AM
.
Cytokine adsorption and ECMO in patients with COVID-19
.
Lancet Respir Med
.
2021 Aug
9
8
e71
.
31.
Schopka
S
,
Philipp
A
,
Müller
T
,
Lubnow
M
,
Lunz
D
,
Unterbuchner
C
.
The impact of interleukin serum levels on the prognosis of patients undergoing venoarterial extracorporeal membrane oxygenation
.
Artif Organs
.
2020 Aug
44
8
837
45
.
32.
Pappalardo
F
,
Schulte
C
,
Pieri
M
,
Schrage
B
,
Contri
R
,
Soeffker
G
.
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock
.
Eur J Heart Fail
.
2017 Mar
19
3
404
12
.
33.
Supady
A
,
Weber
E
,
Rieder
M
,
Lother
A
,
Niklaus
T
,
Zahn
T
.
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial
.
Lancet Respir Med
.
2021 Jul
9
7
755
62
.
34.
Scharf
C
,
Schroeder
I
,
Paal
M
,
Winkels
M
,
Irlbeck
M
,
Zoller
M
.
Can the cytokine adsorber CytoSorb® help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
.
Ann Intensive Care
.
2021 Jul
11
1
115
.
35.
Wendel Garcia
PD
,
Hilty
MP
,
Held
U
,
Kleinert
EM
,
Maggiorini
M
.
Cytokine adsorption in severe, refractory septic shock
.
Intensive Care Med
.
2021 Nov
47
11
1334
6
.
You do not currently have access to this content.